Margarita M. Phillips BOSTON and LAUSANNE, Switzerland, July 29. 10, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced that Chief Financial Officer Ross Muken will attend and be a panelist at Canon Genuity 42n/a Annual Growth Conference on Thursday, August 11, 2022 at the InterContinental Hotel in Boston, MA, USA.
Ross will join other industry leaders for the panel”Leveraging Omics-based data and analytics to take precision health to the next level,” starting at 9:30 a.m. EST.
A live webcast and replay of the session will be available on the investor relations section of the SOPHiA GENETICS website at https://ir.sophiagenetics.com.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a health technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life science research. He is the creator of the SOPHiA DDM™ platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal datasets and different diagnostic modalities. The SOPHiA DDM™ platform and associated solutions, products and services are currently used by more than 790 hospitals, laboratories and biopharmaceutical institutions worldwide. For more information, visit SOPHiAGENETICS.COM or connect on Twitter, LinkedIn and Instagram. Where others see data, we see answers.
Investor contacts:
Jennifer Pottage
Head of Investor Relations
[email protected]
Media Contact:
Don Granese
Public relations
[email protected]
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XVAQ4QHWE5JD5J6A25CNBMK5PM.jpg)
